MoonLake Immunotherapeutics Class A stock price
문레이크 이뮤노테라퓨틱스NASDAQ:MLTX · Nasdaq · Healthcare · sector #17$10.95-3.78%
2026-10-06 closeLoading chart…
Today's signals · No active technical signal.
Signal details →MoonLake Immunotherapeutics Class A last closed at $10.95 (-3.78%) on 2026-10-06. Listed on Nasdaq. Trailing 12 months PER is -3.1×. Its overall grade ranks 552 of 740 stocks in Healthcare.
About this company
MoonLake Immunotherapeutics Class A last closed at $10.95 (-3.78%) on 2026-10-06. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C · 552/740
Valuation grade B+
Related stocks
- AbbVieCompetitor
염증성 질환 치료제 시장의 대형 경쟁사
- Johnson & JohnsonCompetitor
면역·염증성 자가면역 치료제 분야의 글로벌 경쟁사
- Eli LillyCompetitor
염증성 질환 및 면역질환 치료제 개발 경쟁사
About MoonLake Immunotherapeutics Class A
- What technical signals does MoonLake Immunotherapeutics Class A (MLTX) have?
- MoonLake Immunotherapeutics Class A current technical signals: no active technical signal.
- Is MoonLake Immunotherapeutics Class A a cup-and-handle pattern?
- No. MoonLake Immunotherapeutics Class A has no valid Cup signal right now.
- What published figures are available for MoonLake Immunotherapeutics Class A?
- Market cap: $954.28M. Trailing 12 months PER: -3.1×. Latest quarter PBR: 1.89×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about MoonLake Immunotherapeutics Class A, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy